GLUE - Company ID 0001826457
As of 2026-11-06, Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of $844.79 M, making it the #2572 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $844.79 M |
| 2026-11-05 | $865.91 M |
| 2026-11-04 | $926.74 M |
| 2026-11-03 | $885.77 M |
| 2026-11-02 | $898.02 M |
| 2026-11-01 | $909.00 M |
| 2026-10-31 | $909.00 M |
| 2026-10-30 | $890.41 M |
| 2026-10-29 | $918.29 M |
| 2026-10-28 | $911.53 M |
| 2026-10-27 | $897.17 M |
| 2026-10-26 | $885.34 M |
As of 2026-11-06, Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of $844.79 M, making it the #2572 most valuable US-listed company.
Monte Rosa Therapeutics, Inc. is the #2572 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $915.76 M |
| 2026-10-24 | $915.76 M |
| 2026-10-23 | $915.76 M |
| 2026-10-22 | $931.81 M |
| 2026-10-21 | $947.86 M |
| 2026-10-20 | $959.69 M |
| 2026-10-19 | $900.55 M |
| 2026-10-18 | $822.83 M |
| 2026-10-17 | $822.83 M |
| 2026-10-16 | $822.83 M |
| 2026-10-15 | $849.44 M |
| 2026-10-14 | $831.28 M |
| 2026-10-13 | $835.50 M |
| 2026-10-12 | $888.72 M |
| 2026-10-11 | $870.14 M |
| 2026-10-10 | $870.14 M |
| 2026-10-09 | $870.14 M |
| 2026-10-08 | $871.83 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.